Cepheid Closes $345M Offering of Convertible Senior Notes | GenomeWeb

NEW YORK (GenomeWeb News) – Cepheid said after the close of the market on Monday that it has closed its $345 million offering of 1.25 percent convertible senior notes.

The offering includes $300 million of notes that were sold to qualified institutional investors and $45 million of notes that were issued pursuant to the exercise of an overallotment option by the notes' initial purchasers, Morgan Stanley and Jefferies. The notes are due in 2021.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.